A new perspective on modic type 1 changes in degenerative disc disease: a systematic evidence-based educational review.

In 30 seconds

This PRISMA-compliant systematic evidence-based review synthesized studies of MRI-defined Modic type 1 changes (MC1) in degenerative disc disease, covering pain associations, natural history, diagnostic discrimination, and treatment response. Nineteen studies were included in the qualitative synthesis. The evidence suggests MC1 is a dynamic, potentially inflammatory and nociceptive imaging phenotype that is frequently associated with low back pain, but the association varies and does not establish causality. Treatment evidence was limited: antibiotic therapy was not supported for routine use, while basivertebral nerve ablation appeared promising in selected patients.

Key findings

• Nineteen studies were included in the qualitative synthesis; MC1 was frequently associated with low back pain, but association strength varied and causality was not established.
• Longitudinal evidence indicates MC1 may develop, persist, regress, or change into other Modic subtypes over time.
• Therapeutic evidence was limited; antibiotic therapy was not supported for routine use because randomized evidence was conflicting.
• Basivertebral nerve ablation appeared promising in selected patients, but the review describes the overall treatment evidence as limited.

Why it matters

MC1 may reflect active disc-endplate degeneration and possible vertebrogenic pain, but it is not a specific or universally causal pain marker. Interpreting it alongside other degenerative findings, clinical features, and potential imaging mimics can help avoid attributing symptoms to an MRI finding alone. The review also highlights uncertainty in prognosis and treatment response.

What to keep in mind

The evidence was limited by heterogeneous study quality, variable MRI protocols, small or selected cohorts, incomplete confounder adjustment, and limited long-term comparative data.